Announcements Trials

Browse Landscape

Phase

Status

Terminated 5 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Histologic Type 1 Neoplasms 1 Lymphoma, B-Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Gemcitabine 21 130-nm albumin-bound paclitaxel 8 irinotecan sucrosofate 7 Oxaliplatin 7 Leucovorin 7 Fluorouracil 7 Taxes 5 Drug Therapy 5 Albumin-Bound Paclitaxel 4 toripalimab 3 Specimen Handling 3 S 1 (combination) 3 Paclitaxel 3 Irinotecan 3 Injections 3 zimberelimab 2 surufatinib 2 camrelizumab 2 Pemetrexed 2 Pancreaticoduodenectomy 2 Magnetic Resonance Spectroscopy 2 Exercise 2 Capecitabine 2 Blood Specimen Collection 2 Biopsy 2 trastuzumab deruxtecan 1 sintilimab 1 semaglutide 1 potassium oxonate 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Pancreatic Neoplasms × ALT-803 × Clear all

NCT07488884 2026-04-29

ResQ108B-PANC

ImmunityBio, Inc.

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡